Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • MRNA vs THC✓SelectedUSD · THCMRNA vs THC performance historyLatest closeAs of-3.63%11/16
Stock and ETF performance explorer

MRNA vs THC

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+1,057.4%
THC return
+1,118.8%
Excess return
-61.4%
Maximum drawdown
-95.4%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 10y.

Portfolio and benchmark returns by period
PeriodPortfolioTHCExcessAlpha
1D-3.6%+1.9%-5.6%-3.8%
7D-20.0%+0.9%-20.9%-20.0%
30D-1.3%+9.1%-10.3%-2.0%
3M+240.0%+8.8%+231.1%+237.1%
6M+339.0%+48.2%+290.7%+321.5%
YTD+630.0%+46.7%+583.3%+599.2%
1Y+769.1%+51.1%+717.9%+729.6%
3Y+181.2%+401.4%-220.2%+140.2%
5Y-8.1%+265.8%-273.9%-21.2%
All+1,057.4%+1,118.8%-61.4%+832.8%

Cumulative growth

Daily Returns

Daily percentage return beside THC.

Daily Out/Under-Performance

Portfolio return minus THC return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × THC return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 10y: compounded portfolio wealth divided by compounded THC wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

10y analysis · Full analysis span regression · 6 months rolling